Last reviewed · How we verify
Bisoprolol-Amlodipine FDC
At a glance
| Generic name | Bisoprolol-Amlodipine FDC |
|---|---|
| Also known as | Concor AM® |
| Sponsor | Merck KGaA, Darmstadt, Germany |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bisoprolol-Amlodipine FDC CI brief — competitive landscape report
- Bisoprolol-Amlodipine FDC updates RSS · CI watch RSS
- Merck KGaA, Darmstadt, Germany portfolio CI